Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qin Mu

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Oncology|April 10, 2012
All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiationQiu-Jun Yang, Long-Yang Zhou, Yu-Qin Mu, et al.
Scientific Reports|March 15, 2026
Capecitabine combined with fecal microbiota transplantation prevents colorectal cancer progression through correction of microbial dysbiosis and immune regulationMuhammad Arshad, Chong-Yuan Zhang, Zhan-Kui Gao, et al.
European Journal of Pharmacology|March 22, 2025
To explore the potential combined treatment strategy for colorectal cancer: Inhibition of cancer stem cells and enhancement of intestinal immune microenvironmentDan-Qi Xu, Jia-Xin Geng, Zhan-Kui Gao, et al.
Oncotarget|December 2, 2017
MicroRNA-34a functions as a tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh esophageal squamous cell carcinomaXiao-Bin Cui, Hao Peng, Ran-Ran Li, et al.
World Journal of Hepatology|May 31, 2016
Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2aMing-Hui Li, Yao Xie, Lu Zhang, et al.
Frontiers in Microbiology|December 2, 2024
Suppressed oncogenic molecules involved in the treatment of colorectal cancer by fecal microbiota transplantationXing Han, Bo-Wen Zhang, Wei Zeng, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|January 9, 2016
[Efficacy of pegylated-interferon alpha-2a treatment in patients with HBeAg-positive chronic hepatitis B and partial viral response to nucleoside analogue therapy]Ming-Hui Li, Lei-Ping Hu, Lu Zhang, et al.
Frontiers in Microbiology|May 5, 2023
Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responsesHao Yu, Xing-Xiu Li, Xing Han, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|March 4, 2014
[Study on the etiology of acute hepatitis hospitalized patients in Beijing Ditan Hospital from 2002 to 2011]Ge Shen, Lu Zhang, Yan-Li Zhang, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|March 21, 2014
[Analyse related factors of impact and prognosis of 73 cases of severe hepatitis]Jun-Mei Zhao, Lu Zhang, Qing-Wei Du, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Oncology|April 10, 2012
All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiationQiu-Jun Yang, Long-Yang Zhou, Yu-Qin Mu, et al.
Scientific Reports|March 15, 2026
Capecitabine combined with fecal microbiota transplantation prevents colorectal cancer progression through correction of microbial dysbiosis and immune regulationMuhammad Arshad, Chong-Yuan Zhang, Zhan-Kui Gao, et al.
European Journal of Pharmacology|March 22, 2025
To explore the potential combined treatment strategy for colorectal cancer: Inhibition of cancer stem cells and enhancement of intestinal immune microenvironmentDan-Qi Xu, Jia-Xin Geng, Zhan-Kui Gao, et al.
Oncotarget|December 2, 2017
MicroRNA-34a functions as a tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh esophageal squamous cell carcinomaXiao-Bin Cui, Hao Peng, Ran-Ran Li, et al.
World Journal of Hepatology|May 31, 2016
Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2aMing-Hui Li, Yao Xie, Lu Zhang, et al.
Frontiers in Microbiology|December 2, 2024
Suppressed oncogenic molecules involved in the treatment of colorectal cancer by fecal microbiota transplantationXing Han, Bo-Wen Zhang, Wei Zeng, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|January 9, 2016
[Efficacy of pegylated-interferon alpha-2a treatment in patients with HBeAg-positive chronic hepatitis B and partial viral response to nucleoside analogue therapy]Ming-Hui Li, Lei-Ping Hu, Lu Zhang, et al.
Frontiers in Microbiology|May 5, 2023
Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responsesHao Yu, Xing-Xiu Li, Xing Han, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|March 4, 2014
[Study on the etiology of acute hepatitis hospitalized patients in Beijing Ditan Hospital from 2002 to 2011]Ge Shen, Lu Zhang, Yan-Li Zhang, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|March 21, 2014
[Analyse related factors of impact and prognosis of 73 cases of severe hepatitis]Jun-Mei Zhao, Lu Zhang, Qing-Wei Du, et al.
Pageof 5